 Myokardia NASDAQ:MYOK and CELYAD SAADR NASDAQ:CYAD are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Risk and Volatility Myokardia has a beta of 2.07, suggesting that its share price is 107 more ... 